CN Patent

CN1732952B — 一种治疗高血压的复方分散片

Assigned to Jiangsu Wangao Pharmaceutical Co ltd · Expires 2010-04-07 · 16y expired

What this patent protects

本发明涉及包含缬沙坦和氢氯噻嗪的药物口服制剂，具体地说是涉及增强缬沙坦和氢氯噻嗪有益效果的分散片剂型。它能迅速起效并增强活性成分的有益效果，且可容易地、没有任何不适地给药。

USPTO Abstract

本发明涉及包含缬沙坦和氢氯噻嗪的药物口服制剂，具体地说是涉及增强缬沙坦和氢氯噻嗪有益效果的分散片剂型。它能迅速起效并增强活性成分的有益效果，且可容易地、没有任何不适地给药。

Drugs covered by this patent

Patent Metadata

Patent number: CN1732952B
Jurisdiction: CN
Classification: —
Expires: 2010-04-07
Drug substance claim: No
Drug product claim: No
Assignee: Jiangsu Wangao Pharmaceutical Co ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.